Global AI in Bioinformatics Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143099
- Pages: 225
-
Format:
Short Description
Global AI in Bioinformatics Market, By Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Other Sectors), Industry Trends and Forecast to 2029
Market Definition
Bioinformatics is a sub-discipline that has to do with the analysis of sequences of biological molecules. It usually refers to genes, DNA, RNA, or protein, and is particularly useful in comparing genes and other sequences in proteins and other sequences within an organism or between organisms, looking at the evolutionary relationships between organisms, and using the patterns that exist across DNA and protein sequences to figure out what their function is.
Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of biology to specialize in. And out of the many, bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of computer science, statistics, and biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, and others.
In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify the quality target.
Market Segmentation
The AI in bioinformatics market is categorized into five notable segments such as offering, type, products and services, application, and other sectors.
On the basis of offering, the global AI in bioinformatics market is segmented into software, services, and others
On the basis of type, the global AI in bioinformatics market is segmented into machine learning, deep learning, and others
On the basis of products and services, the global AI in bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services
On the basis of application, the global AI in bioinformatics market is segmented into genomics, microarrays, system biology, text mining, chemoinformatics & drug design, proteomics, transcriptomics, DNA sequencing, metabolomics, and others
On the basis of sector, the global AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and other sectors
Market Players
Some of the major players operating in the global AI in bioinformatics market are:
JADBio & Gnosis Data Analysis
Fios Genomics
SOPHiA GENETICS
Biomax Informatics Inc.
DNASTAR
Ardigen (Parent Company Selvita Group)
Source BioScience
QIAGEN
NeoGenomics Laboratories
CelbridgeScience
Eurofins Scientific
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Insilico Medicine
Strand Life Sciences
Dassault Systmes
iNDX.Ai
Paige AI, Inc.
SomaLogic Operating Co., Inc.
Elucidata
TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW OF GLOBAL AI IN BIOINFORMATICS MARKET 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 OFFERING LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 MARKET SECTOR COVERAGE GRID 41
2.11 VENDOR SHARE ANALYSIS 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 50
4.2 PORTERS FIVE FORCES 51
5 MARKET OVERVIEW 52
5.1 DRIVERS 54
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST 54
5.1.2 GROWING DEMAND FOR BIOINFORMATICS 55
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 55
5.2 RESTRAINTS 56
5.2.1 HIGH COST OF INSTRUMENTATION 56
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS 56
5.3 OPPORTUNITIES 57
5.3.1 RISE IN HEALTHCARE EXPENDITURE 57
5.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 57
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 58
5.4 CHALLENGES 58
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY 58
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB 59
6 GLOBAL AI IN BIOINFORMATICS MARKET, BY OFFERING 60
6.1 OVERVIEW 61
6.2 SERVICES 64
6.3 SOFTWARE 64
6.4 OTHERS 65
7 GLOBAL AI IN BIOINFORMATICS MARKET, BY TYPE 67
7.1 OVERVIEW 68
7.2 MACHINE LEARNING 71
7.3 DEEP LEARNING 71
7.4 OTHERS 72
8 GLOBAL AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES 74
8.1 OVERVIEW 75
8.2 BIOINFORMATICS SERVICES 78
8.2.1 DATA ANALYSIS 79
8.2.2 SEQUENCING SERVICES 79
8.2.3 DATABASE MANAGEMENT 79
8.2.4 OTHERS 79
8.3 BIOINFORMATICS PLATFORMS 79
8.3.1 SEQUENCE ANALYSIS PLATFORMS 80
8.3.2 SEQUENCE ALIGNMENT PLATFORMS 80
8.3.3 STRUCTURAL ANALYSIS PLATFORMS 81
8.3.4 SEQUENCE MANIPULATION PLATFORMS 81
8.3.5 OTHERS 81
8.4 KNOWLEDGE MANAGEMENT TOOLS 81
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 82
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 82
9 GLOBAL AI IN BIOINFORMATICS MARKET, BY APPLICATION 83
9.1 OVERVIEW 84
9.2 GENOMICS 87
9.3 CHEMOINFORMATICS & DRUG DESIGN 87
9.4 PROTEOMICS 88
9.5 DNA SEQUENCING 89
9.6 SYSTEM BIOLOGY 90
9.7 TRANSCRIPTOMICS 91
9.8 TEXT MINING 92
9.9 MICROARRAYS 93
9.10 METABOLOMICS 94
9.11 OTHERS 95
10 GLOBAL AI IN BIOINFORMATICS MARKET, BY SECTOR 96
10.1 OVERVIEW 97
10.2 MEDICAL BIOTECHNOLOGY 100
10.3 ANIMAL BIOTECHNOLOGY 100
10.4 PLANT BIOTECHNOLOGY 101
10.5 ENVIRONMENTAL BIOTECHNOLOGY 102
10.6 FORENSIC BIOTECHNOLOGY 103
10.7 OTHERS 104
11 GLOBAL AI IN BIOINFORMATICS MARKET, BY REGION 105
11.1 OVERVIEW 106
11.2 NORTH AMERICA 111
11.2.1 U.S. 118
11.2.2 CANADA 121
11.2.3 MEXICO 124
11.3 EUROPE 127
11.3.1 U.K. 134
11.3.2 FRANCE 137
11.3.3 GERMANY 140
11.3.4 SPAIN 143
11.3.5 ITALY 146
11.3.6 RUSSIA 149
11.3.7 NETHERLANDS 152
11.3.8 SWITZERLAND 155
11.3.9 TURKEY 158
11.3.10 BELGIUM 161
11.3.11 REST OF EUROPE 164
11.4 ASIA-PACIFIC 165
11.4.1 CHINA 172
11.4.2 JAPAN 175
11.4.3 SOUTH KOREA 178
11.4.4 INDIA 181
11.4.5 AUSTRALIA 184
11.4.6 SINGAPORE 187
11.4.7 THAILAND 190
11.4.8 MALAYSIA 193
11.4.9 INDONESIA 196
11.4.10 PHILIPPINES 199
11.4.11 REST OF ASIA-PACIFIC 202
11.5 SOUTH AMERICA 203
11.5.1 BRAZIL 210
11.5.2 ARGENTINA 213
11.5.3 REST OF SOUTH AMERICA 216
11.6 MIDDLE EAST AND AFRICA 217
11.6.1 SOUTH AFRICA 224
11.6.2 ISRAEL 227
11.6.3 SAUDI ARABIA 230
11.6.4 U.A.E 233
11.6.5 EGYPT 236
11.6.6 REST OF MIDDLE EAST AND AFRICA 239
12 GLOBAL AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE 240
12.1 COMPANY SHARE ANALYSIS: GLOBAL 240
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 241
12.3 COMPANY SHARE ANALYSIS: EUROPE 242
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 243
13 SWOT ANALYSIS 244
14 COMPANY PROFILES 245
14.1 ILLUMINA, INC. 245
14.1.1 COMPANY SNAPSHOT 245
14.1.2 REVENUE ANALYSIS 245
14.1.3 COMPANY SHARE ANALYSIS 246
14.1.4 PRODUCT PORTFOLIO 246
14.1.5 RECENT DEVELOPMENTS 246
14.2 DASSAULT SYSTEMES 247
14.2.1 COMPANY SNAPSHOT 247
14.2.2 REVENUE ANALYSIS 247
14.2.3 COMPANY SHARE ANALYSIS 248
14.2.4 PRODUCT PORTFOLIO 248
14.2.5 RECENT DEVELOPMENT 248
14.3 EUROFINS SCIENTIFIC 249
14.3.1 COMPANY SNAPSHOT 249
14.3.2 REVENUE ANALYSIS 249
14.3.3 COMPANY SHARE ANALYSIS 250
14.3.4 PRODUCT PORTFOLIO 250
14.3.5 RECENT DEVELOPMENTS 250
14.4 THERMO FISHER SCIENTIFIC INC. 251
14.4.1 COMPANY SNAPSHOT 251
14.4.2 REVENUE ANALYSIS 251
14.4.3 COMPANY SHARE ANALYSIS 252
14.4.4 PRODUCT PORTFOLIO 252
14.4.5 RECENT DEVELOPMENTS 252
14.5 QIAGEN 253
14.5.1 COMPANY SNAPSHOT 253
14.5.2 COMPANY SHARE ANALYSIS 253
14.5.3 PRODUCT PORTFOLIO 253
14.5.4 RECENT DEVELOPMENTS 253
14.6 SOPHIA GENETICS 254
14.6.1 COMPANY SNAPSHOT 254
14.6.2 PRODUCT PORTFOLIO 254
14.6.3 RECENT DEVELOPMENT 254
14.7 ARDIGEN 255
14.7.1 COMPANY SNAPSHOT 255
14.7.2 PRODUCT PORTFOLIO 255
14.7.3 RECENT DEVELOPMENTS 255
14.8 BIOMAX INFORMATICS AG 256
14.8.1 COMPANY SNAPSHOT 256
14.8.2 PRODUCT PORTFOLIO 256
14.8.3 RECENT DEVELOPMENT 256
14.9 CELBRIDGESCIENCE. 257
14.9.1 COMPANY SNAPSHOT 257
14.9.2 PRODUCT PORTFOLIO 257
14.9.3 RECENT DEVELOPMENTS 257
14.10 DNASTAR 258
14.10.1 COMPANY SNAPSHOT 258
14.10.2 PRODUCT PORTFOLIO 258
14.10.3 RECENT DEVELOPMENTS 258
14.11 ELUCIDATA 259
14.11.1 COMPANY SNAPSHOT 259
14.11.2 PRODUCT PORTFOLIO 259
14.11.3 RECENT DEVELOPMENTS 259
14.12 FIOS GENOMICS 260
14.12.1 COMPANY SNAPSHOT 260
14.12.2 PRODUCT PORTFOLIO 260
14.12.3 RECENT DEVELOPMENTS 260
14.13 INDX. AI. 261
14.13.1 COMPANY SNAPSHOT 261
14.13.2 PRODUCT PORTFOLIO 261
14.13.3 RECENT DEVELOPMENTS 261
14.14 INSILICO MEDICINE 262
14.14.1 COMPANY SNAPSHOT 262
14.14.2 PRODUCT PORTFOLIO 262
14.14.3 RECENT DEVELOPMENTS 262
14.15 JADBIO & GNOSIS DATA ANALYSIS 264
14.15.1 COMPANY SNAPSHOT 264
14.15.2 PRODUCT PORTFOLIO 264
14.15.3 RECENT DEVELOPMENTS 264
14.16 NEOGENOMICS LABORATORIES 266
14.16.1 COMPANY SNAPSHOT 266
14.16.2 REVENUE ANALYSIS 266
14.16.3 PRODUCT PORTFOLIO 267
14.16.4 RECENT DEVELOPMENTS 267
14.17 PAIGE AI, INC. 268
14.17.1 COMPANY SNAPSHOT 268
14.17.2 PRODUCT PORTFOLIO 268
14.17.3 RECENT DEVELOPMENTS 268
14.18 SOMALOGIC OPERATING CO., INC. 269
14.18.1 COMPANY SNAPSHOT 269
14.18.2 PRODUCT PORTFOLIO 269
14.18.3 RECENT DEVELOPMENTS 269
14.19 SOURCE BIOSCIENCE. 270
14.19.1 COMPANY SNAPSHOT 270
14.19.2 PRODUCT PORTFOLIO 270
14.19.3 RECENT DEVELOPMENTS 270
14.20 STRAND LIFE SCIENCES 271
14.20.1 COMPANY SNAPSHOT 271
14.20.2 PRODUCT PORTFOLIO 271
14.20.3 RECENT DEVELOPMENTS 271
15 QUESTIONNAIRE 272
16 RELATED REPORTS 275
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
